TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 9 | 11 | 21 | 17 | 41 | 35 | 22 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 50 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/10/20 07:54 | 6/9/20 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Keler Tibor | NJ | O | EVP,CSO | P | 15 | 2.99 | 0 | 5 | 212 | 7 | D | ||||||||||||||
6/18/18 08:15 | 6/15/18 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Keler Tibor | NJ | O | EVP,CSO | P | 10 | 0.5929 | 0 | 17 | 87 | 35 | D | ||||||||||||||
9/6/16 13:04 | 9/2/16 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Keler Tibor | NJ | O | EVP,CSO | P | 10 | 3.32 | 9 | 3 | 19 | 19 | D | -79 | -76 | -12 | -31 | -29 | -25 | -4 | -2 | 5 | 11 | 27 | 6 | 3 | |
8/11/11 13:42 | 8/11/11 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Keler Tibor | MA | O | SVP,CSO | P | 13 | 2.50 | 1 | 5 | 46 | 16 | D | -62 | -49 | -31 | -35 | -31 | -33 | -32 | -12 | 9 | 15 | 9 | 24 | 111 | 93 |
9/13/10 10:41 | 9/13/10 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Keler Tibor | MA | O | SVP,CSO | P | 18 | 3.52 | 3 | 5 | New | 5 | D | -68 | -37 | -33 | -32 | -32 | -21 | -19 | 1 | 13 | 8 | 27 | 20 | 10 | -23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |